JSSH
VERA icon

J. Safra Sarasin Holding’s Vera Therapeutics VERA Stock Holding History

J. Safra Sarasin Holding’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$524K Sell
13,033
-39,294
-75% -$1.69M 0.01% 404
2025
Q4 		$2.65M Sell
52,327
-2,990
-5% -$106K 0.04% 177
2025
Q3 		$1.61M Buy
55,317
+25,750
+87% +$595K 0.03% 234
2025
Q2 		$697K Buy
+29,567
New +$665K 0.01% 328

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

J. Safra Sarasin Holding's VERA Position: Q1 2026 in Review

J. Safra Sarasin Holding reduced its Vera Therapeutics (VERA) stake by 75% in Q1 2026, selling an estimated $1.69M and leaving 13,033 shares worth $524K. The position accounts for 0.01% of the portfolio, ranked #404.

J. Safra Sarasin Holding first reported a position in VERA in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.65M in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • J. Safra Sarasin Holding held 13,033 shares of Vera Therapeutics worth $524K as of Q1 2026.
  • J. Safra Sarasin Holding sold 39,294 Vera Therapeutics shares in Q1 2026, an estimated $1.69M.
  • Vera Therapeutics made up 0.01% of J. Safra Sarasin Holding's portfolio in Q1 2026, its #404 holding.
  • J. Safra Sarasin Holding first reported a position in Vera Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • J. Safra Sarasin Holding's Vera Therapeutics position peaked at $2.65M in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q1 2026, filed 4 May 2026.